What United Healthcare Doesn't Want You To Know - YouTube

America's Healthcare Crisis: $5 Trillion System Delivers Poor Outcomes Despite Highest Global Spending

When I was young, just entering the workforce, I signed up for an HMO through my employer, because it was cheap, convenient, and I didn't expect to get sick. Is I advanced in age, I watched my diet, exercised, and started to realize that eventually I might get sick. When I married and had a family, I realized that I had to make sure good health care was available for my children. So I started to research the healthcare system to find the best options within those offered by my employer, and that usually pointed to a PPO with a good network.When I retired, I had to go through another research project with all the Medicare options.Part C Medicare Advantage plans tempted, but I became aware of their limitations, so stayed with the original, but still had to choose a supplement for B and drug plan part D. I thought I was set. When I got cancer and was put on very expensive medications, I discovered that despite all my planning, I could still go broke. I took a step back to look at the whole healthcare system worldwide versus the US and realized we had serious problems.

The American healthcare system, consuming nearly $5 trillion annually and 18% of GDP, ranks last among developed nations for health outcomes while maintaining the highest costs globally, according to recent analysis.

Americans face a triple threat of aggressive insurance claim denials (16% average, up to 32% for some providers), consolidated healthcare providers driving up costs, and pharmaceutical prices far exceeding international rates for identical medications.

Insurance companies' "deny, depose and defend" tactics have led to 67% of U.S. bankruptcies being healthcare-related, while 40% of Americans report delaying medical care due to costs. The system's administrative overhead accounts for 40% of hospital expenses – far higher than other developed nations.

Private equity's growing influence has worsened outcomes, with studies showing PE-owned nursing homes experiencing 10% higher mortality rates. Meanwhile, pharmaceutical companies have doubled payments to doctors from $6.5 billion to $12.8 billion since 2014, raising ethical concerns about prescription practices.

Despite having advanced facilities and skilled physicians, the system's fundamental misalignment of incentives has resulted in Americans seeing doctors 50% less than other wealthy nations while having a life expectancy three years lower than comparable countries.

"It is a system that would reject care to a sick child because of prior authorization," notes the analysis, highlighting the human cost of prioritizing profits over patient care in America's healthcare landscape.

Insurance

Key problems with US health insurance include:

Insurance Company Practices:
- Deny 16% of all claims, with some companies like UnitedHealthCare denying up to 32%
- Care denials increased 20-56% from 2022-2023
- 75% of Medicare Advantage denials were later overturned
- Less than 1% of denials appealed due to complex process

Market Concentration:
- 73% of commercial markets highly concentrated
- 71% of Medicare Advantage markets concentrated
- 90% of ACA markets concentrated
- Mergers lead to higher premiums rather than savings

Administrative Burden:
- 40% of hospital expenses are administrative
- Multiple billing codes, payment processes, and authorization protocols
- 30% higher costs vs other nations due to administrative overhead
- Prior authorizations delay critical care (30% of radiation oncologists report patient harm)

Vertical Integration:
- UnitedHealth employs 10,000 physicians directly
- Has ties to additional 80,000 doctors (10% of US physicians)
- Companies expanding into provider space to increase profits
- Leads to further market concentration and higher costs

Impact:
- 67% of US bankruptcies are healthcare-related
- 40% of Americans delay medical care due to costs
- System incentivizes denial of care to maximize profits
- Peer review process often uses unqualified reviewers (qualified only 15% of time)

Providers

Healthcare providers face several key issues:

Doctors:
- Artificially limited supply (2.6 physicians per 1000 vs OECD average 3.7)
- AMA restricted medical schools and residencies 20 years ago
- Higher compensation than other countries due to supply constraints
- 75% now work for corporate groups/hospitals

Consolidation:
- 1000 mergers among 5000 hospitals in 20 years
- Private equity firms acquiring practices
- PE control leads to 13-18% price increases
- Example: US Anesthesia Partners charging 30-40% higher rates in Denver

Quality Issues:
- PE ownership linked to 10% higher mortality in nursing homes
- 25% increase in hospital complications under PE
- 38% increase in bloodstream infections
- Quality declines while costs rise

Leadership Compensation:
- Nonprofit hospital CEO example: UPMC chief earned $13M in 2022
- Excessive executive pay even in nonprofit sector
- Focus on profit over patient care
- Administrative burden pushing independent physicians to join larger groups

The system's structure incentivizes consolidation and profit maximization while potentially compromising care quality.

Big Pharma

Here are the key problems with Big Pharma in America:

Pricing & Market Power:
- Controls 44% of global pharmaceutical market ($600B)
- Charges significantly higher prices in US for identical drugs
- Example: Gleevec costs $90,000 more annually in US vs other countries
- Dramatic price variations even within US (same drug can cost 4x more between regions)

Regulatory Issues:
- US government prohibited from direct price negotiations with pharma companies
- Medicare Noninterference clause prevents leveraging collective bargaining power
- Medicaid drug rebate program led companies to shift costs to other payers

Ethical Concerns:
- Payments to doctors increased from $6.5B to $12.8B since 2014
- Uses kickbacks and incentives to influence prescribing practices
- Creates conflicts of interest through research funding and consulting fees
- Notable scandals: Novartis (2010), Pfizer (2014), Purdue Pharma (opioid crisis)

While companies cite R&D costs (20-40% of revenue) to justify prices, they maintain high profit margins while charging other countries significantly less for the same drugs.

US Healthcare System

The US spends more on healthcare than any other country, yet Americans visit doctors less often and have lower life expectancy than other wealthy nations. How did the world’s most advanced economy end up with such a broken healthcare system?

In this video, we explore the complexities of US healthcare, revealing how insurance companies, healthcare providers, and pharmaceutical giants prioritize profits over patients. From rising administrative costs to insurance claim denials, physician shortages, and outrageous drug pricing, the system is riddled with inefficiencies and greed.

We begin with the dark realities of health insurance—where 40% of hospital expenses are tied to administration, and claim denials have surged by over 50%. Next, we uncover how doctor shortages were intentionally created, driving up physician salaries and consolidating hospital groups. Finally, we examine the pharmaceutical industry, which charges Americans far more than the rest of the world for the same drugs, while engaging in ethically questionable practices.

This isn’t just a story of high costs; it’s a story of lives impacted by a system designed to prioritize corporate interests over public well-being. Despite the US having world-class technology and top medical professionals, access to this quality care remains elusive for the average American. Join us as we ask: Is greed always good? Can the US learn from other nations and build a system that works for everyone?

Don’t forget to subscribe to 2&20 for more deep dives into economics, politics, and policy

Chapters

1. 00:00 – Intro

2. 01:41 – Health Insurance

3. 08:51 – Healthcare Providers

4. 14:09 – Pharma

5. 18:21 - Conclusion

Transcript Summary

Here's a summary of the key points about the US healthcare system from the transcript:

The system has three main components causing issues:

1. Insurance Companies:

- Deny 16% of all claims (up to 32% for some companies)
- Create excessive administrative burden (40% of hospital expenses)
- Have high market concentration (73%+ in most markets)
- Vertically integrate by employing doctors
- Use prior authorizations that delay critical care

2. Healthcare Providers:

- Doctors' compensation is significantly higher than other countries
- Supply artificially limited by AMA's past policies
- Increasing consolidation through private equity
- PE ownership linked to worse outcomes (10% higher mortality in nursing homes)
- Even non-profit hospitals show excess (UPMC CEO made $13M in 2022)

3. Pharmaceutical Industry:

- US represents 44% of global pharma market ($600B)
- Same drugs cost significantly more than other countries
- Prices vary dramatically between states
- Companies cannot be directly negotiated with by government
- Rising payments to doctors ($12.8B in incentives/kickbacks)

Overall impact:

- US spends $5T (18% of GDP) on healthcare annually
- Americans see doctors 50% less than other wealthy nations
- Life expectancy is 3 years lower than comparable countries
- 67% of US bankruptcies are healthcare-related
- System works well for wealthy but fails general population
- Ranks last among 10 high-income countries for health outcomes

The transcript concludes that regardless of public/private debate, the current system is failing to deliver adequate care while maintaining the highest costs globally.

High Costs, Complex Systems: Why U.S. Healthcare Leaves Patients Frustrated Compared to Global Peers

By [Chat GPT]

January 26, 2025

As the debate over healthcare reform continues to polarize Americans, patients in the United States are growing increasingly vocal about the system’s shortcomings compared to other advanced nations. From skyrocketing costs to complex insurance networks, U.S. patients face challenges that their counterparts in countries like Canada, the United Kingdom, France, and even Mexico often avoid.

Cost: A Constant Burden

For many Americans, the price of healthcare is a persistent source of stress. The U.S. spends more per capita on healthcare than any other country, yet millions of patients struggle with high out-of-pocket expenses. Even those with insurance often face steep premiums, deductibles, and co-pays. By contrast, countries like Canada, the UK, and France operate under universal healthcare systems where patients pay little or nothing at the point of care. In Mexico, while the public system can be overburdened, private healthcare often remains significantly cheaper than its U.S. equivalent.

“I skipped my medication this month because I couldn’t afford the refill,” said one Texas resident. “I don’t understand why the same drug costs half as much in Canada.”

Insurance Woes and Coverage Gaps

Insurance coverage in the U.S. is another major source of frustration. Many Americans rely on employer-sponsored insurance, which can leave gaps for those who are unemployed or underemployed. Even with coverage, the system’s complexity often leads to confusion over what services are covered and surprise medical bills.

“You have to fight with insurance companies constantly,” said Sarah, a New York resident. “I spent hours on the phone just trying to figure out why my claim was denied.”

In countries like Canada, the UK, and France, healthcare is decoupled from employment, providing a safety net for all citizens and residents. Patients in Mexico’s public system, while not immune to bureaucratic challenges, often experience a more straightforward process.

Access and Wait Times

Geography and socioeconomic status also play a significant role in access to healthcare for Americans. Rural areas often lack sufficient providers, and patients may face long waits for specialist appointments. While countries like Canada and the UK also report delays for non-urgent procedures, their universal systems ensure basic access for everyone.

France is frequently cited as a model for balancing access and quality, with shorter wait times than Canada or the UK. Mexico presents a mixed picture, with rural areas underserved but urban centers offering quick access through private facilities for those who can afford it.

Disparities in Health Outcomes

Despite the high spending, U.S. health outcomes often lag behind peer nations. Life expectancy, maternal mortality rates, and chronic disease management are areas where the U.S. performs poorly. In contrast, Canada, the UK, and France benefit from a stronger emphasis on preventive care and equitable access.

“It’s heartbreaking that we pay so much and still rank lower in basic health metrics,” said a healthcare advocate from California.

Pharmaceutical Prices: A Pain Point

The cost of prescription drugs remains another area of contention. U.S. patients often pay significantly more for the same medications available at lower prices in Canada, the UK, and Mexico, where governments negotiate or regulate drug prices. As a result, cross-border trips to purchase medications are common.

The Way Forward

While the U.S. healthcare system boasts advanced technology and world-class specialists, the patient experience is often marred by high costs, complexity, and inequities. Advocates for reform point to systems in Canada, the UK, and France as examples of how universal healthcare can address these challenges. However, critics warn that adopting similar models could introduce new issues, such as longer wait times or higher taxes.

“We don’t need to copy any one system,” said a policy expert. “But we do need to learn from what works globally and adapt it to our unique context.”

As policymakers debate the future of healthcare in America, one thing is clear: patients are demanding change, and the world is watching how the U.S. responds.

The US Healcare System as seen from a patients point of view versus other Nations

The U.S. healthcare system has distinct challenges that set it apart from systems in other advanced nations like Canada, the UK, France, and even Mexico. Here are some of the major issues from the perspective of patients, alongside comparisons to these countries:

1. Cost of Healthcare

U.S. Patients: The U.S. has the highest healthcare costs globally. Patients often face significant out-of-pocket expenses, even with insurance. Many people forego necessary treatments or medications due to high costs.
- Compared to Other Nations:
  - Canada, UK, and France: These countries offer universal or single-payer healthcare systems where patients face minimal out-of-pocket costs. Taxes fund healthcare, and basic care is generally free at the point of service.
  - Mexico: While Mexico’s healthcare system is more affordable, quality varies significantly between public and private facilities. Private care can be costly but is still often cheaper than U.S. prices.

2. Insurance and Coverage Gaps

U.S. Patients: Coverage is tied to employment for many, creating gaps for unemployed individuals or those in transition. Even insured patients face high premiums, deductibles, and co-pays.
- Compared to Other Nations:
  - Canada, UK, and France: Healthcare is not dependent on employment, and all citizens and permanent residents have access to a basic level of care.
  - Mexico: The public system (Instituto Mexicano del Seguro Social or IMSS) covers most employed individuals, while Seguro Popular or its successor programs aim to assist the uninsured.

3. Access to Care

U.S. Patients: Access varies widely by geography, income, and insurance status. Rural areas often lack sufficient healthcare providers, and waiting times for specialist appointments can be lengthy.
- Compared to Other Nations:
  - Canada: While care is universally accessible, long wait times for non-urgent procedures and specialists are a persistent issue.
  - UK: The National Health Service (NHS) ensures universal access, but similar to Canada, non-urgent care can involve long waits.
  - France: Generally regarded as having better access with shorter wait times compared to Canada and the UK.
  - Mexico: Access depends on whether patients use public or private services. The public system often has long wait times, while private care is faster but expensive.

4. Complexity of the System

U.S. Patients: The system is fragmented, requiring patients to navigate multiple insurers, providers, and billing processes. Surprise billing and opaque pricing add stress.
- Compared to Other Nations:
  - Canada, UK, and France: These systems are more centralized, making navigation simpler for patients.
  - Mexico: While less complex than the U.S., patients in Mexico may encounter challenges in transitioning between public and private sectors.

5. Health Outcomes

U.S. Patients: Despite high spending, the U.S. often lags in key health metrics like life expectancy, maternal mortality, and chronic disease management.
- Compared to Other Nations:
  - Canada, UK, and France: These countries often achieve better outcomes for less cost due to emphasis on preventive care and equitable access.
  - Mexico: Outcomes are mixed, with public health challenges like obesity and diabetes affecting metrics, though universal programs improve access for many.

6. Pharmaceutical Costs

U.S. Patients: Prescription drugs are significantly more expensive due to limited price controls and high development costs.
- Compared to Other Nations:
  - Canada and France: Governments negotiate or regulate drug prices, making medications much more affordable.
  - UK: The NHS negotiates drug prices, ensuring affordability.
  - Mexico: Medications are often cheaper than in the U.S., with many people crossing the border for lower-cost prescriptions.

7. Health Inequities

U.S. Patients: Disparities in care are prominent based on race, income, and geography. Marginalized communities face worse outcomes and barriers to access.
- Compared to Other Nations:
  - Canada, UK, and France: While inequities exist, universal systems aim to reduce disparities significantly.
  - Mexico: Inequities are notable, especially between rural and urban populations.

Conclusion

From the patient’s perspective, the U.S. healthcare system is often viewed as expensive, complex, and inequitable compared to the more accessible and affordable systems in Canada, the UK, France, and Mexico. However, the U.S. excels in specialized and cutting-edge medical care for those who can afford it, making it a global leader in medical innovation. Other nations balance cost and access better through universal systems but may face challenges like longer wait times or variable quality.

What Is to Be Done?

Proposed Solutions and Their Tradeoffs

Expanding Universal Coverage
- Proposals: Implementing a single-payer system (e.g., “Medicare for All”) or introducing a public option.
- Benefits: Ensures access for all, reduces administrative costs.
- Tradeoffs: Higher taxes, potential for longer wait times, disruption of private insurance.
Strengthening Employer-Based Coverage
- Proposals: Expanding employer incentives to provide insurance.
- Benefits: Builds on the existing system, offers stability.
- Tradeoffs: Leaves gaps for unemployed individuals, maintains complexity.
Regulating Drug Prices
- Proposals: Allowing Medicare to negotiate prices, introducing price caps.
- Benefits: Reduces costs for patients.
- Tradeoffs: May impact pharmaceutical innovation, risk of shortages.
Promoting Preventive Care
- Proposals: Expanding funding for public health initiatives, incentivizing preventive services.
- Benefits: Improves health outcomes, lowers long-term costs.
- Tradeoffs: Requires upfront investment, delayed returns.
Increasing Transparency and Competition
- Proposals: Mandating price transparency, encouraging competition.
- Benefits: Helps patients make informed decisions, could lower costs.
- Tradeoffs: Complexity in comparing options, resistance from providers.
Expanding Medicaid
- Proposals: Expanding eligibility, incentivizing state participation.
- Benefits: Covers more low-income individuals, leverages existing infrastructure.
- Tradeoffs: Cost burden on federal and state budgets, political resistance.
Addressing Social Determinants of Health
- Proposals: Investing in housing, education, and nutrition programs.
- Benefits: Tackles root causes of poor health, reduces inequities.
- Tradeoffs: Requires cross-sector collaboration, long-term benefits are hard to measure.
Digital and Telehealth Expansion
- Proposals: Increasing access to telehealth, subsidizing broadband.
- Benefits: Expands care access in rural areas, reduces costs.
- Tradeoffs: Digital divide may exclude some populations, regulatory challenges.

For More Depth

Sources

Review our sources ► https://pastebin.com/mjv7kXKV

· Check out our website, newsletter, and more ► https://linktr.ee/2and20

· Get in touch ► 2and20official@gmail.com

Search This Blog

Informed Prostate Cancer Patient Support